Lee Jinho, Jung Sung-Chul, Hong Young Bin, Yoo Jeong Hyun, Koo Heasoo, Lee Ja Hyun, Hong Hyun Dae, Kim Sang-Beom, Chung Ki Wha, Choi Byung-Ok
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135‑710, Republic of Korea.
Department of Biochemistry, Ewha Womans University School of Medicine, Seoul 120‑750, Republic of Korea.
Mol Med Rep. 2016 Jul;14(1):33-40. doi: 10.3892/mmr.2016.5209. Epub 2016 May 4.
Mutations in the optic atrophy 1 gene (OPA1) are associated with autosomal dominant optic atrophy and 20% of patients demonstrate extra-ocular manifestations. In addition to these autosomal dominant cases, only a few syndromic cases have been reported thus far with compound heterozygous OPA1 mutations, suggestive of either recessive or semi‑dominant patterns of inheritance. The majority of these patients were diagnosed with Behr syndrome, characterized by optic atrophy, ataxia and peripheral neuropathy. The present study describes a 10-year-old boy with Behr syndrome presenting with early‑onset severe optic atrophy, sensorimotor neuropathy, ataxia and congenital cataracts. He had optic atrophy and was declared legally blind at six years old. Electrophysiological, radiological, and histopathological findings were compatible with axonal sensorimotor polyneuropathy. At birth, he presented with a congenital cataract, which has not been previously described in patients with OPA1 mutations. Whole exome sequencing indicated a pair of novel compound heterozygous mutations: p.L620fs*13 (c.1857‑1858delinsT) and p.R905Q (c.G2714A). Neither mutation was observed in controls (n=300), and thus, they were predicted to be pathogenic by multiple in silico analyses. The mutation sites were highly conserved throughout different vertebrate species. The patients parents did not have any ophthalmic or neurologic symptoms and the results of electrophysiological studies were normal, suggestive of an autosomal recessive pattern of inheritance. The present study identified novel compound heterozygous OPA1 mutations in a patient with recessive optic atrophy, sensorimotor neuropathy and congenital cataracts, indicating an expansion of the clinical spectrum of pathologies associated with OPA1 mutations. Thus, OPA1 gene screening is advisable in the workup of patients with recessive optic atrophy, particularly with Behr syndrome and cataracts.
视神经萎缩1基因(OPA1)突变与常染色体显性视神经萎缩相关,20%的患者表现出眼外症状。除了这些常染色体显性病例外,迄今为止仅报道了少数伴有OPA1复合杂合突变的综合征病例,提示为隐性或半显性遗传模式。这些患者大多数被诊断为贝赫综合征,其特征为视神经萎缩、共济失调和周围神经病变。本研究描述了一名患有贝赫综合征的10岁男孩,表现为早发性严重视神经萎缩、感觉运动性神经病变、共济失调和先天性白内障。他患有视神经萎缩,6岁时被判定为法定失明。电生理、放射学和组织病理学检查结果与轴索性感觉运动性多发性神经病变相符。出生时,他患有先天性白内障,此前OPA1突变患者中未见此情况。全外显子组测序显示一对新的复合杂合突变:p.L620fs*13(c.1857 - 1858delinsT)和p.R905Q(c.G2714A)。在对照组(n = 300)中均未观察到这两种突变,因此,通过多种计算机分析预测它们具有致病性。这些突变位点在不同脊椎动物物种中高度保守。患者的父母没有任何眼科或神经学症状,电生理研究结果正常,提示为常染色体隐性遗传模式。本研究在一名患有隐性视神经萎缩、感觉运动性神经病变和先天性白内障的患者中鉴定出了新的OPA1复合杂合突变,表明与OPA1突变相关的病理学临床谱有所扩展。因此,对于患有隐性视神经萎缩的患者,尤其是患有贝赫综合征和白内障的患者,建议进行OPA1基因筛查。